http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106242972-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-14
filingDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106242972-B
titleOfInvention Combretastatin prodrug, pharmaceutical preparation and preparation method
abstract The invention discloses a kind of Combretastatin prodrugs, and disclose preparation method, and the present invention discloses the preparation methods of a kind of preparation containing above-mentioned Combretastatin prodrug and said preparation.Combretastatin lipophilic drugs precursor provided in the present invention can fast hydrolyzing discharge active pharmaceutical ingredient, play drug effect;The nanometer formulation being made of Combretastatin lipophilic drugs precursor then can slow release internal drug, be conducive to extend the circulation of drug in vivo, improve the curative effect of drug, there is good potential applicability in clinical practice and application value.
priorityDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0067801-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006089207-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007059118-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9895264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID507393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5356785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8094
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID507393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515188
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424740888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421705909
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474449

Total number of triples: 51.